Development of antibodies and antibody-derived proteins for the prevention and treatment of infectious diseases with epidemic potential

This topic is registered in the EU Funding & Tenders Portal under identifier HORIZON-HLTH-2025-01-DISEASE-03, as part of the Horizon Europe (HORIZON) programme, within call HORIZON-HLTH-2025-01 — "Cluster 1 - Health (Single stage - 2025)".

The snapshot records: published on 2025-05-15; planned opening date 2025-05-22; deadline 2025-09-16; status recorded in the snapshot as Closed (snapshot dated 2026-05-28).

Registered action/grant types from the portal data: topicActions: HORIZON-RIA (HORIZON Research and Innovation Actions). topicMGAs: HORIZON-AG-LS (HORIZON Lump Sum Grant).

The authoritative call document is the PDF published on the topic's portal page at https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/HORIZON-HLTH-2025-01-DISEASE-03. Funding amounts, eligibility, evaluation criteria, and other binding details are stated there; this stub records only the portal metadata fields. A pass-2 agent will transcribe the call document specifics verbatim.